Curi Wealth Management’s DexCom DXCM Stock Holding History

Curi Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	336
2022 Q2	$0	Hold	4	–	–	﹤0.01%	653
2022 Q1	$0	Hold	4	–	–	﹤0.01%	547
2021 Q4	$0	Buy	+4	New	+$575	﹤0.01%	516

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Curi Wealth Management's DXCM Position: Q3 2022 in Review

Curi Wealth Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 4 shares.

Curi Wealth Management first reported a position in DXCM in Q4 2021 and held it in 3 quarters. The position peaked at $0 in Q2 2022. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

Curi Wealth Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
Curi Wealth Management sold 4 DexCom shares in Q3 2022.
Curi Wealth Management first reported a position in DexCom in Q4 2021 and held it in 3 quarters.
Curi Wealth Management's DexCom position peaked at $0 in Q2 2022.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Curi Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.